Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


Articles published in Semin Liver Dis

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    July 2019
  1. BRUSILOVSKAYA K, Konigshofer P, Schwabl P, Reiberger T, et al
    Vascular Targets for the Treatment of Portal Hypertension.
    Semin Liver Dis. 2019 Jul 17. doi: 10.1055/s-0039-1693115.
    PubMed     Text format     Abstract available


  2. CAPPELLI A, Modestino F, Mosconi C, De Benedittis C, et al
    Portal Hypertensive Biliopathy in Adult Patients: Findings and Interventional Radiologic Treatment-A Single-Center Experience.
    Semin Liver Dis. 2019 Jul 4. doi: 10.1055/s-0039-1693514.
    PubMed     Text format     Abstract available


  3. THOMAS E, Baumert TF
    Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses: Experimental Models and Molecular Mechanisms.
    Semin Liver Dis. 2019 Jul 2. doi: 10.1055/s-0039-1685518.
    PubMed     Text format     Abstract available


  4. RIMOLA J
    Heterogeneity of Hepatocellular Carcinoma on Imaging.
    Semin Liver Dis. 2019 Jul 2. doi: 10.1055/s-0039-1693512.
    PubMed     Text format     Abstract available


    June 2019
  5. AFIFY AY, Ibrahim SA, Aldamsisi MH, Zaghloul MS, et al
    Competing Endogenous RNAs in Hepatocellular Carcinoma-The Pinnacle of Rivalry.
    Semin Liver Dis. 2019 Jun 26. doi: 10.1055/s-0039-1688442.
    PubMed     Text format     Abstract available


  6. YANG JD, Liu MC, Kisiel JB
    Circulating Tumor DNA and Hepatocellular Carcinoma.
    Semin Liver Dis. 2019 Jun 21. doi: 10.1055/s-0039-1688503.
    PubMed     Text format     Abstract available


  7. FILLIOL A, Schwabe RF
    Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis.
    Semin Liver Dis. 2019 Jun 21. doi: 10.1055/s-0039-1685539.
    PubMed     Text format     Abstract available


    April 2019
  8. NAULT JC, Letouze E
    Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid.
    Semin Liver Dis. 2019 Apr 30. doi: 10.1055/s-0039-1685516.
    PubMed     Text format     Abstract available


  9. FEHILY SR, Papaluca T, Thompson AJ
    Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review.
    Semin Liver Dis. 2019 Apr 30. doi: 10.1055/s-0039-1685538.
    PubMed     Text format     Abstract available


  10. PATTEN DA, Shepherd EL, Weston C, Shetty S, et al
    Erratum: Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases.
    Semin Liver Dis. 2019 Apr 16. doi: 10.1055/s-0039-1688409.
    PubMed     Text format    


  11. WEINBERG EM, Palecki J, Reddy KR
    Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Semin Liver Dis. 2019 Apr 12. doi: 10.1055/s-0039-1679934.
    PubMed     Text format     Abstract available


    March 2019
  12. RODRIGUES SG, Cardenas A, Escorsell A, Bosch J, et al
    Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis: A Systematic Review and Meta-analysis.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1678726.
    PubMed     Text format     Abstract available


  13. PATTEN DA, Shepherd EL, Weston CJ, Shetty S, et al
    Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1678727.
    PubMed     Text format     Abstract available


  14. MAIERS JL, Malhi H
    Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1681032.
    PubMed     Text format     Abstract available


  15. KIM G, Kang ES
    Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1679956.
    PubMed     Text format     Abstract available


  16. FUJIWARA N, Hoshida Y
    Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1681031.
    PubMed     Text format     Abstract available


    November 2018
  17. LIN YY, Tan CT, Chen CW, Ou DL, et al
    Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.
    Semin Liver Dis. 2018;38:379-388.
    PubMed     Text format     Abstract available


  18. LI Z, Weinman SA
    Regulation of Hepatic Inflammation via Macrophage Cell Death.
    Semin Liver Dis. 2018;38:340-350.
    PubMed     Text format     Abstract available


  19. HENKEL AS
    Unfolded Protein Response Sensors in Hepatic Lipid Metabolism and Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2018;38:320-332.
    PubMed     Text format     Abstract available


  20. KHAMBU B, Yan S, Huda N, Liu G, et al
    Homeostatic Role of Autophagy in Hepatocytes.
    Semin Liver Dis. 2018;38:308-319.
    PubMed     Text format     Abstract available


  21. NADEAU BA, Fecher LA, Owens SR, Razumilava N, et al
    Liver Toxicity with Cancer Checkpoint Inhibitor Therapy.
    Semin Liver Dis. 2018;38:366-378.
    PubMed     Text format     Abstract available


  22. HASSAN A, Fontana RJ
    Liver Injury Associated with Sporting Activities.
    Semin Liver Dis. 2018;38:357-365.
    PubMed     Text format     Abstract available


  23. LIM C, Lahat E, Osseis M, Sotirov D, et al
    Liver Transplantation for Neuroendocrine Tumors: What Have We Learned?
    Semin Liver Dis. 2018;38:351-356.
    PubMed     Text format     Abstract available


  24. KEITEL V, Haussinger D
    Role of TGR5 (GPBAR1) in Liver Disease.
    Semin Liver Dis. 2018;38:333-339.
    PubMed     Text format     Abstract available


  25. REICHERT MC, Lammert F
    ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
    Semin Liver Dis. 2018;38:299-307.
    PubMed     Text format     Abstract available


    August 2018
  26. DOU L, Ono Y, Chen YF, Thomson AW, et al
    Erratum: Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.
    Semin Liver Dis. 2018;38:298.
    PubMed     Text format    


  27. DEUTSCH-LINK S, Fortuna D, Weinberg EM
    A Comprehensive Review of Hepatic Sarcoid.
    Semin Liver Dis. 2018;38:284-297.
    PubMed     Text format     Abstract available


  28. LIU PH, Huo TI, Miksad RA
    Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
    Semin Liver Dis. 2018;38:242-251.
    PubMed     Text format     Abstract available


  29. PIANO S, Brocca A, Angeli P
    Renal Function in Cirrhosis: A Critical Review of Available Tools.
    Semin Liver Dis. 2018;38:230-241.
    PubMed     Text format     Abstract available


  30. SCHEPIS F, Turco L, Bianchini M, Villa E, et al
    Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis.
    Semin Liver Dis. 2018;38:215-229.
    PubMed     Text format     Abstract available


  31. SHI SH, Zhai ZL, Zheng SS
    Pyogenic Liver Abscess of Biliary Origin: The Existing Problems and Their Strategies.
    Semin Liver Dis. 2018;38:270-283.
    PubMed     Text format     Abstract available


  32. ALFERINK LJM, Kiefte-de Jong JC, Darwish Murad S
    Potential Mechanisms Underlying the Role of Coffee in Liver Health.
    Semin Liver Dis. 2018;38:193-214.
    PubMed     Text format     Abstract available


    May 2018
  33. DOU L, Ono Y, Chen YF, Thomson AW, et al
    Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.
    Semin Liver Dis. 2018;38:170-180.
    PubMed     Text format     Abstract available


  34. RIMBAS M, Di Maurizio L, Rizzatti G, Gasbarrini A, et al
    Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review.
    Semin Liver Dis. 2018;38:145-159.
    PubMed     Text format     Abstract available


  35. YANG L, Wu T, Li J, Li J, et al
    Bacterial Infections in Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2018;38:121-133.
    PubMed     Text format     Abstract available


  36. LESAFFRE E
    Noninferiority Clinical Trials: The Good, the Bad, and the Ugly.
    Semin Liver Dis. 2018;38:97-102.
    PubMed     Text format     Abstract available


    February 2018
  37. TREBICKA J
    Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?
    Semin Liver Dis. 2018;38:87-96.
    PubMed     Text format     Abstract available


  38. HLADY RA, Robertson KD
    Genetic and Epigenetic Heterogeneity in Normal Liver Homeostasis and Its Implications for Liver Disease and Hepatocellular Cancer.
    Semin Liver Dis. 2018;38:41-50.
    PubMed     Text format     Abstract available


  39. ANDRADE RJ, Medina-Caliz I, Gonzalez-Jimenez A, Garcia-Cortes M, et al
    Hepatic Damage by Natural Remedies.
    Semin Liver Dis. 2018;38:21-40.
    PubMed     Text format     Abstract available


  40. AJMERA V, Loomba R
    Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
    Semin Liver Dis. 2018;38:14-20.
    PubMed     Text format     Abstract available


  41. DARA L
    The Receptor Interacting Protein Kinases in the Liver.
    Semin Liver Dis. 2018;38:73-86.
    PubMed     Text format     Abstract available


  42. LALAZAR G, Simon SM
    Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
    Semin Liver Dis. 2018;38:51-59.
    PubMed     Text format     Abstract available


  43. MANN JP, Valenti L, Scorletti E, Byrne CD, et al
    Nonalcoholic Fatty Liver Disease in Children.
    Semin Liver Dis. 2018;38:1-13.
    PubMed     Text format     Abstract available


    November 2017
  44. RICH NE, Parikh ND, Singal AG
    Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance.
    Semin Liver Dis. 2017;37:296-304.
    PubMed     Text format     Abstract available


    August 2017
  45. KAMBADAKONE A, Baliyan V, Zhu AX
    Functional Imaging and Assessment of Antitumor Activity in Systemic Therapy for Hepatocellular Carcinoma.
    Semin Liver Dis. 2017;37:259-274.
    PubMed     Text format    


  46. HEIKENWALDER M, Pikarsky E
    Learning the Roles of the Hepatic Adaptive Immune System in Hepatocellular Carcinoma-Nature's Guide for Successful Cancer Immunotherapy.
    Semin Liver Dis. 2017;37:210-218.
    PubMed     Text format    


    May 2017
  47. LALIOTI V, Tsubota A, Sandoval IV
    Disorders in Hepatic Copper Secretion: Wilson's Disease and Pleomorphic Syndromes.
    Semin Liver Dis. 2017;37:175-188.
    PubMed     Text format    


    February 2017
  48. PARES A
    Novel Treatment Strategies for Primary Biliary Cholangitis.
    Semin Liver Dis. 2017;37:60-72.
    PubMed     Text format     Abstract available


  49. SANTOS-LASO A, Izquierdo-Sanchez L, Lee-Law PY, Perugorria MJ, et al
    New Advances in Polycystic Liver Diseases.
    Semin Liver Dis. 2017;37:45-55.
    PubMed     Text format     Abstract available


  50. TRIPODI A
    Hemostasis in Acute and Chronic Liver Disease.
    Semin Liver Dis. 2017;37:28-32.
    PubMed     Text format     Abstract available


  51. MORALES-RUIZ M, Santel A, Ribera J, Jimenez W, et al
    The Role of Akt in Chronic Liver Disease and Liver Regeneration.
    Semin Liver Dis. 2017;37:11-16.
    PubMed     Text format     Abstract available


  52. CAMPANA L, Iredale JP
    Regression of Liver Fibrosis.
    Semin Liver Dis. 2017;37:1-10.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: